FTC

Kaiser

Trump’s view on drug costs: Talk vs. the truth

President Donald Trump has railed against the high price of prescription drugs, yet many Americans aren’t seeing a change in what they pay out-of-pocket. Here’s a look at the rhetoric thus far versus the results.

presented by
Pharma

Pfizer-Allergan ruling sets a dangerous precedent

Fundamentally, my biggest concern with the new rules regards the importance of predictability in business. Strategic planning, essential to running sustainable enterprises, requires the predictability of transparent and forward-looking laws, along with proper due process and accountability.